An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
0 Response to "Differences in reporting methods can over- or under-estimate the safety of drugs"
Post a Comment